Cutaneous Toxicities With Amivantamab for Non-Small Cell Lung Cancer: A Practical Guide and Best Practices.
- Published in:
- Clinical Journal of Oncology Nursing, 2024, v. 28, n. 6, p. 559, doi. 10.1188/24.CJON.559-566
- By:
- Publication type:
- Article
Works by Xia, Karen
Results: 4
1
2
Cutaneous Toxicities With Amivantamab for Non-Small Cell Lung Cancer: A Practical Guide and Best Practices.
- Published in:
- Clinical Journal of Oncology Nursing, 2024, v. 28, n. 5, p. 1
- By:
- Publication type:
- Article
3
Cutaneous Toxicities With Amivantamab for Non--Small Cell Lung Cancer (NSCLC) With Exon 20 Insertion Mutation (ex20ins): A Practical Guide and Best Practices for Management.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2023, v. 14, n. 11, p. 353
- By:
- Publication type:
- Article
4
3-LB: Golimumab (GLM) Preserves ß-Cell Function and Reduces Insulin Use and Hypoglycemia in Children and Young Adults with Recently Diagnosed Type 1 Diabetes (T1D): The Phase 2 T1GER Study.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-3-LB
- By:
- Publication type:
- Article